tiprankstipranks
Bausch Health Companies (MX:BHCN)
:BHCN
Mexico Market
BHCN
Bausch Health Companies
RESEARCH TOOLSreports

Bausch Health Companies (BHCN) Ratios

0 Followers

Bausch Health Companies Ratios

MX:BHCN's free cash flow for Q2 2026 was $0.65. For the 2026 fiscal year, MX:BHCN's free cash flow was decreased by $ and operating cash flow was $0.27. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 1.44 1.47 0.86 1.30 1.08
Quick Ratio
 1.08 1.08 0.62 0.94 0.80
Cash Ratio
 0.40 0.32 0.17 0.22 0.14
Solvency Ratio
 <0.01 0.05 0.05 0.02 0.05
Operating Cash Flow Ratio
 0.40 0.33 0.24 0.24 -0.18
Short-Term Operating Cash Flow Coverage
 2.08 4.65 0.60 2.29 -1.69
Net Current Asset Value
$ -19.07B$ -19.80B$ -21.07B$ -21.84B$ -21.18B
Leverage Ratios
Debt-to-Assets Ratio
 0.84 0.81 0.81 0.82 0.81
Debt-to-Equity Ratio
 -11.73 -38.35 -16.90 -21.91 -30.01
Debt-to-Capital Ratio
 1.09 1.03 1.06 1.05 1.03
Long-Term Debt-to-Capital Ratio
 1.10 1.03 1.07 1.05 1.04
Financial Leverage Ratio
 -14.00 -47.59 -20.74 -26.76 -37.12
Debt Service Coverage Ratio
 0.68 1.65 0.64 1.11 1.47
Interest Coverage Ratio
 1.72 1.35 1.11 0.73 0.94
Debt to Market Cap
 9.00 8.17 7.27 7.66 9.15
Interest Debt Per Share
 59.70 61.61 62.51 64.99 61.41
Net Debt to EBITDA
 9.26 5.76 7.24 9.74 7.02
Profitability Margins
Gross Profit Margin
71.82%60.90%71.10%70.78%70.90%
EBIT Margin
8.06%21.28%16.16%10.71%16.43%
EBITDA Margin
18.86%33.05%29.32%25.15%35.43%
Operating Profit Margin
25.44%21.28%16.06%11.00%16.86%
Pretax Profit Margin
-6.74%3.57%1.74%-4.45%-1.59%
Net Profit Margin
-10.12%1.53%-0.48%-6.76%-2.61%
Continuous Operations Profit Margin
-10.07%1.17%-0.75%-6.98%-2.61%
Net Income Per EBT
150.00%42.78%-27.54%151.79%164.34%
EBT Per EBIT
-26.51%16.80%10.80%-40.50%-9.42%
Return on Assets (ROA)
-4.43%0.61%-0.17%-2.16%-0.83%
Return on Equity (ROE)
88.77%-28.89%3.60%57.93%30.64%
Return on Capital Employed (ROCE)
13.63%10.04%7.82%4.18%6.30%
Return on Invested Capital (ROIC)
13.07%3.24%-2.96%4.09%6.16%
Return on Tangible Assets
-10.15%1.53%-0.47%-6.10%-2.54%
Earnings Yield
-48.24%6.21%-1.55%-20.24%-9.34%
Efficiency Ratios
Receivables Turnover
 4.80 4.45 4.50 4.38 4.54
Payables Turnover
 5.16 6.82 4.24 3.56 4.54
Inventory Turnover
 1.91 2.51 1.74 1.66 2.17
Fixed Asset Turnover
 5.18 5.05 5.41 4.63 5.08
Asset Turnover
 0.44 0.40 0.36 0.32 0.32
Working Capital Turnover Ratio
 6.34 20.99 60.92 10.95 22.72
Cash Conversion Cycle
 196.54 173.79 204.35 200.95 168.28
Days of Sales Outstanding
 76.11 82.00 81.15 83.28 80.42
Days of Inventory Outstanding
 191.21 145.31 209.26 220.23 168.30
Days of Payables Outstanding
 70.78 53.52 86.07 102.55 80.44
Operating Cycle
 267.32 227.31 290.42 303.51 248.72
Cash Flow Ratios
Operating Cash Flow Per Share
 4.80 3.72 4.34 2.83 -2.01
Free Cash Flow Per Share
 3.71 2.63 3.42 2.08 -2.75
CapEx Per Share
 1.09 1.09 0.92 0.75 0.74
Free Cash Flow to Operating Cash Flow
 0.77 0.71 0.79 0.74 1.37
Dividend Paid and CapEx Coverage Ratio
 4.41 3.41 4.70 3.79 -2.72
Capital Expenditure Coverage Ratio
 4.41 3.41 4.70 3.79 -2.72
Operating Cash Flow Coverage Ratio
 0.09 0.07 0.07 0.05 -0.04
Operating Cash Flow to Sales Ratio
 0.17 0.13 0.17 0.12 -0.09
Free Cash Flow Yield
61.34%37.87%42.30%25.99%-43.88%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -2.09 16.14 -64.60 -4.94 -10.71
Price-to-Sales (P/S) Ratio
 0.21 0.25 0.31 0.33 0.28
Price-to-Book (P/B) Ratio
 -1.30 -4.65 -2.32 -2.86 -3.28
Price-to-Free Cash Flow (P/FCF) Ratio
 1.65 2.64 2.36 3.85 -2.28
Price-to-Operating Cash Flow Ratio
 1.28 1.87 1.86 2.83 -3.12
Price-to-Earnings Growth (PEG) Ratio
 <0.01 -0.04 0.70 -0.03 0.14
Price-to-Fair Value
 -1.30 -4.65 -2.32 -2.86 -3.28
Enterprise Value Multiple
 10.38 6.51 8.29 11.07 7.81
Enterprise Value
 21.22B 22.46B 23.41B 24.37B 22.47B
EV to EBITDA
 10.37 6.51 8.29 11.07 7.81
EV to Sales
 1.96 2.15 2.43 2.78 2.77
EV to Free Cash Flow
 15.24 23.04 18.62 32.06 -22.56
EV to Operating Cash Flow
 11.79 16.29 14.66 23.61 -30.87
Tangible Book Value Per Share
 -39.40 -41.81 -46.09 -48.56 -47.20
Shareholders’ Equity Per Share
 -4.72 -1.49 -3.48 -2.80 -1.91
Tax and Other Ratios
Effective Tax Rate
 -0.49 0.67 1.43 -0.57 -0.64
Revenue Per Share
 28.94 28.16 26.15 24.00 22.44
Net Income Per Share
 -2.93 0.43 -0.13 -1.62 -0.59
Tax Burden
 1.50 0.43 -0.28 1.52 1.64
Interest Burden
 -0.84 0.17 0.11 -0.42 -0.10
Research & Development to Revenue
 0.06 0.06 0.06 0.07 0.07
SG&A to Revenue
 0.32 0.33 0.34 0.26 0.26
Stock-Based Compensation to Revenue
 0.01 0.02 0.02 0.02 0.02
Income Quality
 -1.63 11.49 -22.18 -1.69 3.43
Currency in USD